{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:41Z","timestamp":1772165741328,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Soft-tissue metastasis (STM) is a relatively rare, but not exceptional, manifestation of lung cancer. The purpose of this study was to evaluate the imaging features of STM from lung cancer using fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT), and assess the impact of STM detected at baseline PET\/CT on patient survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Out of 4543 patients with lung cancer who underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in our hospital between January 2013 and September 2018, 85 were diagnosed with STM (78 at baseline PET\/CT and 7 at restaging PET\/CT) and included in the imaging study. We conducted a comparative survival analysis between patients with stage 4 lung cancer with and without STM at baseline PET\/CT (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200978 in each group) and performed univariate and multivariate analyses to investigate the factors affecting the prognosis of lung cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 219 lesions were identified by\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT: 215 were detected by PET and 139 by CT. Muscle STM were primarily found in the hip and upper limb muscle, whereas subcutaneous STM were mainly distributed in the chest, abdomen, and back. In 68 patients, STM were found incidentally during routine\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT staging. Isolated STM were detected in 6 patients, whose tumor staging and treatment were affected by PET\/CT findings. There were no significant differences in the 1-, 3-, and 5-year survival rates between patients with and without STM at baseline PET\/CT. Brain and adrenal metastases, but not STM, were associated with poor prognosis of stage 4 lung cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We described the PET\/CT imaging characteristics of STM from lung cancer, and confirmed that PET\/CT can detect unsuspected STM to change the staging and treatment of some patients. Our analysis indicates that STM is not a useful prognostic indicator for patients with advanced lung cancer, while brain and adrenal metastases portend a poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07080-0","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:37:20Z","timestamp":1593131840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Imaging features and prognostic value of 18F-FDG PET\/CT detection of soft-tissue metastasis from lung cancer: a retrospective study"],"prefix":"10.1186","volume":"20","author":[{"given":"Tingting","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengrun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2381-4296","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"7080_CR1","doi-asserted-by":"publisher","unstructured":"Niu F-Y, Zhou Q, Yang J-J, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer. 2016. https:\/\/doi.org\/10.1186\/s12885-016-2169-5.","DOI":"10.1186\/s12885-016-2169-5"},{"issue":"1","key":"7080_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/mco.2014.410","volume":"3","author":"T Tamura","year":"2015","unstructured":"Tamura T, Kurishima K, Nakazawa K, et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol. 2015;3(1):217\u201321.","journal-title":"Mol Clin Oncol."},{"key":"7080_CR3","doi-asserted-by":"publisher","unstructured":"Nguyen NC, Chaar BT, Osman MM. Prevalence and patterns of soft tissue metastasis: Detection with true whole-body F-18 FDG PET\/CT. BMC Med Imaging. 2007. https:\/\/doi.org\/10.1186\/1471-2342-7-8.","DOI":"10.1186\/1471-2342-7-8"},{"issue":"2","key":"7080_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2214\/ajr.174.2.1740401","volume":"174","author":"ES Pretorius","year":"2000","unstructured":"Pretorius ES, Fishman EK. Helical CT of skeletal muscle metastases from primary carcinomas. AJR Am J Roentgenol. 2000;174(2):401\u20134.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"7080_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3892\/mco.2014.312","volume":"2","author":"DA-S Qiu","year":"2014","unstructured":"Qiu DA-S, Xu L-Y, Shames S. The value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the detection and characterization of soft tissue metastasis. Mol Clin Oncol. 2014;2(5):761\u20136.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"7080_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SMJ.0b013e31818fa11c","volume":"102","author":"SI Sersar","year":"2009","unstructured":"Sersar SI. Skeletal muscle metastasis secondary to lung Cancer. South Med J. 2009;102(1):14\u20135.","journal-title":"South Med J"},{"issue":"5","key":"7080_CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.resinv.2019.06.004","volume":"57","author":"N Kanaji","year":"2019","unstructured":"Kanaji N, Tadokoro A, Watanabe N, et al. Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer. Respir Investig. 2019;57(5):472\u201380.","journal-title":"Respir Investig"},{"issue":"1","key":"7080_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/2000-1967-183","volume":"110","author":"Y Koike","year":"2005","unstructured":"Koike Y, Hatori M, Kokubun S. Skeletal muscle metastasis secondary to cancer--a report of seven cases. Ups J Med Sci. 2005;110(1):75\u201383.","journal-title":"Ups J Med Sci"},{"issue":"1","key":"7080_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncr.23151","volume":"112","author":"JA Plaza","year":"2008","unstructured":"Plaza JA, Perez-Montiel D, Mayerson J, et al. Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer. 2008;112(1):193\u2013203.","journal-title":"Cancer."},{"issue":"4","key":"7080_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01921700","volume":"30","author":"R Stein-Werblowsky","year":"1974","unstructured":"Stein-Werblowsky R. Skeletal muscle and tumour metastasis. Experientia. 1974;30(4):423\u20134.","journal-title":"Experientia."},{"issue":"1","key":"7080_CR11","first-page":"83","volume":"4","author":"JB Strauss","year":"2012","unstructured":"Strauss JB, Shah AP, Chen SA, et al. Psoas muscle metastases in non-small cell lung cancer. J Thorac Dis. 2012;4(1):83\u20137.","journal-title":"J Thorac Dis"},{"issue":"5","key":"7080_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF01753809","volume":"7","author":"L Weiss","year":"1989","unstructured":"Weiss L. Biomechanical destruction of cancer cells in skeletal muscle: a rate-regulator for hematogenous metastasis. Clin Exp Metastasis. 1989;7(5):483\u201391.","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"7080_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/RLU.0b013e3182443e32","volume":"37","author":"AR Khandelwal","year":"2012","unstructured":"Khandelwal AR, Takalkar AM, Lilien DL, et al. Skeletal Muscle Metastases on FDG PET\/CT Imaging. Clin Nucl Med. 2012;37(6):575\u20139.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"7080_CR14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0284185114556927","volume":"56","author":"Y So","year":"2015","unstructured":"So Y, Yi JG, Song I, et al. Detection of skeletal muscle metastasis: torso FDG PET-CT versus contrast-enhanced chest or abdomen CT. Acta Radiol. 2015;56(7):860\u20136.","journal-title":"Acta Radiol"},{"issue":"3","key":"7080_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/RLU.0b013e318208f75d","volume":"36","author":"M Yilmaz","year":"2011","unstructured":"Yilmaz M, Elboga U, Celen Z, et al. Multiple muscle metastases from lung Cancer detected by FDG PET\/CT. Clin Nucl Med. 2011;36(3):245\u20137.","journal-title":"Clin Nucl Med"},{"issue":"15","key":"7080_CR16","first-page":"2057","volume":"16","author":"T Arpaci","year":"2012","unstructured":"Arpaci T, Ugurluer G, Akbas T, et al. Imaging of the skeletal muscle metastases. Eur Rev Med Pharmacol Sci. 2012;16(15):2057\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"7080_CR17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00256-011-1319-8","volume":"41","author":"TM Haygood","year":"2012","unstructured":"Haygood TM, Wong J, Lin JC, et al. Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skelet Radiol. 2012;41(8):899\u2013909.","journal-title":"Skelet Radiol"},{"issue":"2","key":"7080_CR18","doi-asserted-by":"crossref","first-page":"W141","DOI":"10.2214\/AJR.14.13457","volume":"205","author":"S Karunanithi","year":"2015","unstructured":"Karunanithi S, Soundararajan R, Sharma P, et al. Spectrum of physiologic and pathologic skeletal muscle 18F-FDG uptake on PET\/CT. AJR Am J Roentgenol. 2015;205(2):W141\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"7080_CR19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0218492312470571","volume":"21","author":"HH Kwas","year":"2013","unstructured":"Kwas HH, Zendah I, Ghedira H. Skeletal muscle metastases from lung cancer. Asian Cardiovasc Thorac Ann. 2013;21(6):741\u20133.","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"4","key":"7080_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jjco\/hyh036","volume":"34","author":"Y Tuoheti","year":"2004","unstructured":"Tuoheti Y, Okada K, Osanai T. Skeletal muscle metastases of carcinoma: a Clinicopathological study of 12 cases. Jpn J Clin Oncol. 2004;34(4):210\u20134.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"7080_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00330-009-1577-1","volume":"20","author":"A Surov","year":"2010","unstructured":"Surov A, Hainz M, Holzhausen H-J, et al. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol. 2010;20(3):649\u201358.","journal-title":"Eur Radiol"},{"issue":"5","key":"7080_CR22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00261-003-0154-3","volume":"29","author":"E Nagao","year":"2004","unstructured":"Nagao E, Nishie A, Yoshimitsu K. Gluteal muscular and sciatic nerve metastases in advanced urinary bladder carcinoma. Abdom Imaging. 2004;29(5):619\u201322.","journal-title":"Abdom Imaging"},{"issue":"1","key":"7080_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-194007000-00016","volume":"112","author":"OV Batson","year":"1940","unstructured":"Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112(1):138\u201349.","journal-title":"Ann Surg"},{"issue":"7","key":"7080_CR24","first-page":"1907","volume":"19","author":"A Omar","year":"2018","unstructured":"Omar A, Bae S, Arafat W, et al. Site of metastases as prognostic factors in unselected population of stage IV non-small cell lung Cancer. Asian Pac J Cancer Prev. 2018;19(7):1907\u201310.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"7080_CR25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00390866","volume":"113","author":"M Sakurai","year":"1987","unstructured":"Sakurai M, Shinkai T, Eguchi K, et al. Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan). J Cancer Res Clin Oncol. 1987;113(6):563\u20136.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"7080_CR26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-5002(96)00609-5","volume":"16","author":"M Borges","year":"1996","unstructured":"Borges M, Sculier JP, Paesmans M, et al. Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC). Lung Cancer. 1996;16(1):21\u201333.","journal-title":"Lung Cancer"},{"issue":"2","key":"7080_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3816\/CLC.2008.n.018","volume":"9","author":"VR Paralkar","year":"2008","unstructured":"Paralkar VR, Li T, Langer CJ. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective. Clin Lung Cancer 9. 2008;9(2):116\u201321.","journal-title":"Clin Lung Cancer 9"},{"issue":"9","key":"7080_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-018-1182-8","volume":"35","author":"AJW Gibson","year":"2018","unstructured":"Gibson AJW, Li H, D\u2019Sliva A, et al. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer. Med Oncol. 2018;35(9):117.","journal-title":"Med Oncol"},{"issue":"2","key":"7080_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0003-4975(03)01364-X","volume":"78","author":"A Di Giorgio","year":"2004","unstructured":"Di Giorgio A, Sammartino P, Cardini CL, et al. Lung cancer and skeletal muscle metastases. Ann Thorac Surg. 2004;78(2):709\u201311.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"7080_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MNM.0b013e32834e3ad0","volume":"33","author":"J Emmering","year":"2012","unstructured":"Emmering J, Vogel WV, Stokkel MPM. Intramuscular metastases on FDG PET-CT: a review of the literature. Nucl Med Commun. 2012;33(2):117\u201320.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"7080_CR31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","volume":"43","author":"C Pfannenberg","year":"2007","unstructured":"Pfannenberg C, Aschoff P, Schanz S, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43(3):557\u201364.","journal-title":"Eur J Cancer"},{"issue":"11","key":"7080_CR32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/MNM.0000000000000368","volume":"36","author":"A Nocu\u0144","year":"2015","unstructured":"Nocu\u0144 A, Chrapko B. Multiple and solitary skeletal muscle metastases on 18F-FDG PET\/CT imaging. Nucl Med Commun. 2015;36(11):1091\u20139.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"7080_CR33","first-page":"241","volume":"19","author":"K Savas","year":"2015","unstructured":"Savas K, Pinar KZ, Sevda KS, et al. Haematogenous muscular metastasis of non-small cell lung cancer in F-18 fluorodeoxyglucose positron emission tomography\/computed tomography. Contemp Oncol. 2015;19(3):241\u20135.","journal-title":"Contemp Oncol"},{"issue":"6","key":"7080_CR34","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.21873\/anticanres.12638","volume":"38","author":"T Hagi","year":"2018","unstructured":"Hagi T, Nakamura T, Sugino Y, et al. Is FDG-PET\/CT useful for diagnosing pulmonary metastasis in patients with soft tissue sarcoma? Anticancer Res. 2018;38(6):3635\u20139.","journal-title":"Anticancer Res"},{"issue":"5","key":"7080_CR35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s002560050606","volume":"29","author":"JF Glockner","year":"2000","unstructured":"Glockner JF, White LM, Sundaram M, et al. Unsuspected metastases presenting as solitary soft tissue lesions: a fourteen-year review. Skelet Radiol. 2000;29(5):270\u20134.","journal-title":"Skelet Radiol"},{"issue":"1","key":"7080_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0284185113493086","volume":"55","author":"A Surov","year":"2014","unstructured":"Surov A, Pawelka MK, Wienke A, et al. PET\/CT imaging of skeletal muscle metastases. Acta Radiol. 2014;55(1):101\u20136.","journal-title":"Acta Radiol"},{"key":"7080_CR37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1988.6.9.1474","volume":"6","author":"JB Sorensen","year":"1988","unstructured":"Sorensen JB, Hansen HH, Hansen M, et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol. 1988;6:1474\u201380.","journal-title":"J Clin Oncol"},{"key":"7080_CR38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1054\/bjoc.2000.1706","volume":"84","author":"W Jacot","year":"2001","unstructured":"Jacot W, Quantin X, Boher JM, et al. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer. 2001;84:903\u20139.","journal-title":"Br J Cancer"},{"key":"7080_CR39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.04.013","volume":"63","author":"J Sanchez de Cos","year":"2009","unstructured":"Sanchez de Cos J, Sojo Gonzalez MA, Montero MV, et al. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer. 2009;63:140\u20135.","journal-title":"Lung Cancer"},{"key":"7080_CR40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1986.4.5.702","volume":"4","author":"DM Finkelstein","year":"1986","unstructured":"Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long-term survivors in metastatic non-small-cell lung cancer: an eastern cooperative oncology group study. J Clin Oncol. 1986;4:702\u20139.","journal-title":"J Clin Oncol"},{"key":"7080_CR41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cllc.2013.05.002","volume":"14","author":"J Bauml","year":"2013","unstructured":"Bauml J, Mick R, Zhang Y, et al. Determinants of survival in advanced non-small-cell lung cancer in the era of targeted therapies. Clin Lung Cancer. 2013;14:581\u201391.","journal-title":"Clin Lung Cancer"},{"key":"7080_CR42","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110:1860\u20137.","journal-title":"Cancer."},{"key":"7080_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihimaki","year":"2014","unstructured":"Riihimaki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86:78\u201384.","journal-title":"Lung Cancer"},{"key":"7080_CR44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2013.08.012","volume":"65","author":"RR McKay","year":"2014","unstructured":"McKay RR, Kroeger N, Xie W, et al. Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol. 2014;65:577\u201384.","journal-title":"Eur Urol"},{"key":"7080_CR45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2407-13-36","volume":"13","author":"M Riihimaki","year":"2013","unstructured":"Riihimaki M, Thomsen H, Hemminki A, et al. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer. 2013;13:36.","journal-title":"BMC Cancer"},{"key":"7080_CR46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ijc.27988","volume":"133","author":"K Hemminki","year":"2013","unstructured":"Hemminki K, Riihimaki M, Sundquist K, et al. Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer. 2013;133:182\u20139.","journal-title":"Int J Cancer"},{"key":"7080_CR47","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.7150\/jca.30463","volume":"10","author":"J Li","year":"2019","unstructured":"Li J, Zhu H, Sun L, et al. Prognostic value of site-specific metastases in lung cancer: a population based study. J Cancer. 2019;10:3079\u201386.","journal-title":"J Cancer"},{"key":"7080_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","volume":"23","author":"T Hoang","year":"2005","unstructured":"Hoang T, Xu R, Schiller JH, et al. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol. 2005;23:175\u201383.","journal-title":"J Clin Oncol"},{"key":"7080_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2013.7","volume":"10","author":"F Li","year":"2013","unstructured":"Li F, Tian Z. The liver works as a school to educate regulatory immune cells. Cell Mol Immunol. 2013;10:292\u2013302.","journal-title":"Cell Mol Immunol"},{"key":"7080_CR50","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","volume":"14","author":"CN Jenne","year":"2013","unstructured":"Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14:996\u20131006.","journal-title":"Nat Immunol"},{"key":"7080_CR51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SMJ.0b013e3181a56042","volume":"102","author":"K Mohammad","year":"2009","unstructured":"Mohammad K, Sadikot RT. Adrenal insufficiency as a presenting manifestation of nonsmall cell lung cancer. South Med J. 2009;102:665\u20137.","journal-title":"South Med J"},{"key":"7080_CR52","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2147\/TCRM.S164700","volume":"14","author":"N Kanaji","year":"2018","unstructured":"Kanaji N, Mizoguchi H, Inoue T, et al. Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation. Ther Clin Risk Manag. 2018;14:1361\u20138.","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"7080_CR53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12149-008-0151-2","volume":"22","author":"D-S Shin","year":"2008","unstructured":"Shin D-S, Shon O-J, Han D-S, et al. The clinical efficacy of 18F-FDG-PET\/CT in benign and malignant musculoskeletal tumors. Ann Nucl Med. 2008;22(7):603\u20139.","journal-title":"Ann Nucl Med"},{"issue":"10","key":"7080_CR54","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/JTO.0b013e3181b24509","volume":"4","author":"D Pop","year":"2009","unstructured":"Pop D, Nadeemy AS, Venissac N, et al. Skeletal muscle metastasis from non-small cell lung Cancer. J Thorac Oncol. 2009;4(10):1236\u201341.","journal-title":"J Thorac Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T19:26:44Z","timestamp":1624649204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7080"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07080-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16675\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were carried out in accordance with the principles of the Helsinki Declaration. This study was approved by the ethics committee of the Affiliated Hospital of Southwest Medical University (Luzhou, China). Because the study was retrospective, and included data from deceased patients, informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"596"}}